drugset / Trial / NCT03569579
CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction between D797 of D324 in healthy volunteers
Timeline
- Start
- 2018-04-16
- Primary completion
- 2018-05-21
- Completion
- 2018-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | Oral |
| Subject | Memantine | Unknown | 10 mg | Oral |
| Subject | Memantine | Unknown | 20 mg | Oral |